Fibroids and Fertility: When Surgery Is the Right Answer

Uterine fibroids are among the most common tumours in women — benign smooth muscle growths that develop within or around the uterus. By the age of 50, up to 70 to 80% of women will have fibroids of some size. The vast majority of fibroids are asymptomatic and require no treatment whatsoever. For women trying to conceive, however, the question is not simply whether fibroids are present — it is whether the specific fibroids present are in a location and of a size that meaningfully impairs fertility or IVF success.

This guide explains the different types of fibroids, which ones actually matter for fertility, when surgery is evidence-based, and how the surgical vs proceed-to-IVF decision is made in clinical practice.

Understanding Fibroid Classification: Location Is Everything

Fibroids are classified primarily by their location relative to the uterine wall — and this location determines their clinical significance far more than their size.

Submucosal Fibroids (Type 0, 1, 2)

These fibroids grow into the uterine cavity, distorting the endometrial surface. They are the most clinically significant for fertility — even small submucosal fibroids of 1 to 2 cm can reduce IVF implantation rates by 50% or more in some studies. This is because the fibroid disrupts the normal endometrial architecture, impairs blood supply to the overlying endometrium, and creates a hostile local environment for embryo implantation.

Submucosal fibroids are further classified by the proportion of the fibroid within the uterine cavity: Type 0 are entirely within the cavity; Type 1 have more than 50% within the cavity; Type 2 have less than 50% within the cavity but still distort it.

Clinical decision: Submucosal fibroids at any size are generally recommended for removal before fertility treatment. The procedure is hysteroscopic myomectomy — a minimally invasive procedure through the cervix, without any skin incision, performed as a day case.

Intramural Fibroids (Type 3, 4)

These fibroids grow within the muscular wall of the uterus. Their impact on fertility is more nuanced and more controversial than submucosal fibroids:

• Intramural fibroids that do not distort the uterine cavity (type 4, purely within the muscle): Their impact on fertility is less certain. Many meta-analyses suggest a modest negative effect on IVF implantation rates even without cavity distortion, but the evidence is not definitive enough to recommend operating on all intramural fibroids.
• Large intramural fibroids (above 4 to 5 cm): May significantly impair uterine blood flow, alter uterine contractility relevant to implantation, or obstruct the cornual end of the tube where it enters the uterus. Operating becomes more compelling above this size.
• Intramural fibroids that indent the cavity (type 3): Bridging between intramural and submucosal — these should generally be removed before fertility treatment.

Subserosal Fibroids (Type 5, 6, 7)

These fibroids grow outward from the outer surface of the uterus. They generally have minimal impact on fertility unless they are very large (distorting the uterine shape significantly), adjacent to the ovaries (impairing response to stimulation), or compressing the tubes. The evidence does not support routine removal of subserosal fibroids before fertility treatment in the absence of these specific concerns.

Diagnosing and Characterising Fibroids

Transvaginal ultrasound is the first-line investigation and detects most fibroids. However, ultrasound alone can be insufficient to characterise the precise relationship of intramural fibroids to the uterine cavity. Additional tools:

• Saline infusion sonohysterography (SIS/SHG): Saline injected into the cavity under ultrasound — far more sensitive than standard ultrasound for detecting cavity distortion and characterising submucosal fibroids.
• Hysteroscopy: Direct camera inspection of the cavity — the gold standard for cavity assessment.
• MRI: Provides the most complete anatomical picture for complex or multiple fibroids — particularly useful when planning myomectomy to understand the relationship of each fibroid to the cavity and to the outer uterine surface.

When Is Fibroid Surgery (Myomectomy) Recommended Before IVF?

The evidence supports surgery in these specific situations:

• All submucosal fibroids (any size) before IVF or natural conception attempts — the evidence for fertility impact is strong and surgery (hysteroscopic myomectomy) is minimally invasive.
• Intramural fibroids above 4 to 5 cm, or those that indent or distort the uterine cavity — laparoscopic myomectomy in younger women with adequate reserve and time for recovery.
• Multiple fibroids collectively distorting the uterine architecture.
• Any fibroid causing significant symptoms (heavy bleeding causing anaemia, pain, urinary symptoms) regardless of fertility impact.

Surgery is less strongly indicated for: small (below 3 cm) intramural fibroids that do not distort the cavity; subserosal fibroids without specific fertility implications; fibroids in older women with diminished reserve where the 6 to 12 week surgical recovery and healing period represents a significant opportunity cost.

Hysteroscopic Myomectomy: For Submucosal Fibroids

Submucosal fibroids are removed hysteroscopically — a camera is passed through the cervix into the uterine cavity, and a resectoscope (a fine cutting instrument) removes the fibroid from inside the cavity, without any external incision. The procedure is performed under general anaesthesia as a day case. Recovery is typically 1 to 3 days. The uterus heals fully within 4 to 6 weeks, after which fertility treatment can proceed.

Outcomes: Hysteroscopic myomectomy for submucosal fibroids significantly improves implantation rates in IVF and natural conception — with some studies reporting restoration of implantation rates to those of fibroid-free women after successful resection.

Laparoscopic Myomectomy: For Intramural and Subserosal Fibroids

Intramural and subserosal fibroids are removed laparoscopically — through 3 to 4 small incisions in the abdomen, using a camera and instruments guided by the surgeon. The fibroid is excised from the uterine muscle, and the resulting defect in the myometrium is meticulously sutured in multiple layers to restore uterine integrity.

Dr. Sunita Tandulwadkar has performed laparoscopic myomectomy for over 35 years — managing often very large or multiple fibroids using minimally invasive technique. Specific considerations:

• Recovery: 2 to 4 weeks for return to normal activity; full myometrial healing takes 3 to 6 months.
• Post-myomectomy IVF: Most teams recommend waiting 3 to 6 months after laparoscopic myomectomy before starting IVF — to allow adequate myometrial healing before stimulation and transfer.
• Delivery after myomectomy: If the fibroid cavity was opened into the uterine cavity during surgery, subsequent delivery is typically by planned caesarean section — the uterine scar carries risk of rupture in labour, similar to a previous caesarean scar.

Fibroid Surgery Risks: What to Weigh

Every myomectomy carries specific risks that must be factored into the decision:

• Adhesion formation: Surgical trauma to the uterine surface can cause adhesions — fibrous bands that bind the uterus to adjacent structures. Adhesion prevention agents (anti-adhesion barriers, thorough peritoneal lavage) reduce but do not eliminate this risk.
• Blood loss: Myomectomy can cause significant intraoperative bleeding, particularly for large or multiple fibroids. Preoperative GnRH agonist treatment (to shrink fibroids and reduce vascularity) and meticulous surgical technique minimise this.
• Ovarian reserve damage: Not a direct risk of myomectomy itself, but relevant for operations on fibroids adjacent to the ovaries.
• Recurrence: Myomectomy removes existing fibroids but does not prevent new ones. Recurrence rates are significant — attempting pregnancy within 6 to 12 months of myomectomy is advisable to minimise the window for recurrence before conception.

Frequently Asked Questions

Q1. My fibroid is 6 cm but the doctor says it's not affecting my cavity. Should I still remove it before IVF?

At 6 cm, an intramural fibroid warrants careful assessment. If it truly does not distort the cavity on saline sonography or hysteroscopy, the evidence for operating before IVF is less definitive — but the fibroid's size and potential to alter uterine blood flow means the decision should be made with a specialist experienced in both surgery and IVF, not one or the other in isolation. MRI is valuable for planning. Age and ovarian reserve are also relevant — an older woman with low reserve may not be well served by a 6-month surgical recovery.

Q2. Can fibroids grow during IVF stimulation?

Fibroids are oestrogen-sensitive tumours. The supraphysiological oestrogen levels of IVF stimulation can cause transient, modest fibroid growth during the cycle — particularly larger fibroids. This growth is generally temporary and reverses after the cycle. Rapidly growing fibroids or new onset of pain during stimulation should be reported and assessed.

Q3. I had a fibroid removed 2 years ago and it has come back. What now?

Fibroid recurrence after myomectomy is common — particularly for multiple fibroids and in younger women with many years of hormonal exposure ahead. The options for recurrent fibroids are the same as for primary fibroids — hysteroscopic re-resection for new submucosal fibroids, laparoscopic myomectomy for intramural recurrences if compelling, or — for women who have completed their family — definitive surgical options. Each recurrence surgery carries increasing adhesion risk, which must be factored into decision-making.